Stem Cell Veto Could Hurt U.S. Competitiveness, Says William Caldwell, CEO of Advanced Cell Technology

Caldwell's company is working on stem-cell-based therapies for macular degeneration.  Bloomberg TV interviewed him this week for his views. Watch here.